Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>MRI‐based radiomics has been used to diagnose breast lesions; however, little research combining quantitative pharmacokinetic parameters of dynamic contrast‐enhanced MRI (DCE‐MRI) and diffusion kurtosis imaging (DKI) exists.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>To develop and validate a multimodal MRI‐based radiomics model for the differential diagnosis of benign and malignant breast lesions and analyze the discriminative abilities of different MR sequences.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Study Type</h3><p>Retrospective.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Population</h3><p>In all, 207 female patients with 207 histopathology‐confirmed breast lesions (95 benign and 112 malignant) were included in the study. Then 159 patients were assigned to the training group, and 48 patients comprised the validation group.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Field Strength/Sequence</h3><p>T<sub>2</sub>‐weighted (T<sub>2</sub>W), T<sub>1</sub>‐weighted (T<sub>1</sub>W), diffusion‐weighted MR imaging (b‐values = 0, 500, 800, and 2000 seconds/mm<sup>2</sup>) and quantitative DCE‐MRI were performed on a 3.0T MR scanner. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Assessment</h3><p>Radiomics features were extracted from T<sub>2</sub>WI, T<sub>1</sub>WI, DKI, apparent diffusion coefficient (ADC) maps, and DCE pharmacokinetic parameter maps in the training set. Models based on each sequence or combinations of sequences were built using a support vector machine (SVM) classifier and used to differentiate benign and malignant breast lesions in the validation set. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Statistical Tests</h3><p>Optimal feature selection was performed by Spearman's rank correlation coefficients and the least absolute shrinkage and selection operator algorithm (LASSO). Receiver operating characteristic (ROC) curves were used to assess the diagnostic performance of the radiomics models in the validation set.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The area under the ROC curve (AUC) of the optimal radiomics model, including T<sub>2</sub>WI, DKI, and quantitative DCE‐MRI parameter maps was 0.921, with an accuracy of 0.833. The AUCs of the models based on T<sub>1</sub>WI, T<sub>2</sub>WI, ADC map, DKI, and DCE pharmacokinetic parameter maps were 0.730, 0.791, 0.770, 0.788, and 0.836, respectively. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Data Conclusion</h3><p>The model based on radiomics features from T<sub>2</sub>WI, DKI, and quantitative DCE pharmacokinetic parameter maps has a high discriminatory ability for benign and malignant breast lesions. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Level of Evidence</h3><p>3</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Technical Efficacy Stage</h3><p>2</p></section>

Ultrasound‐based radiomics for the differential diagnosis of breast masses: A systematic review and meta‐analysis

Preoperative Prediction Power of Radiomics for Breast Cancer: A Systemic Review and Meta-Analysis

Diagnostic Performance of Radiomics and Deep Learning to Identify Benign and Malignant Soft Tissue Tumors: A Systematic Review and Meta-analysis

Diagnostic performance of ultrasound-based artificial intelligence for predicting key molecular markers in breast cancer: A systematic review and meta-analysis

Comprehensive analysis of clinical utility of three-dimensional ultrasound for benign and malignant breast masses.

A Machine Learning-Based Unenhanced Radiomics Approach to Distinguishing Between Benign and Malignant Breast Lesions Using T2-Weighted and Diffusion-Weighted MRI.

Application of Ultrasonographic Score Evaluation System in Differential Diagnosis of Breast Mass Lesions:Comparison with Pathological Data

The value of radiomics model based on ultrasound image features in the differentiation between minimal breast cancer and small benign breast masses

Deep learning-based computer-aided detection of ultrasound in breast cancer diagnosis: A systematic review and meta-analysis

Radiomics Analysis of Breast Lesions in Combination with Coronal Plane of ABVS and Strain Elastography

Performance of radiomics in the differential diagnosis of parotid tumors: a systematic review

Clinical value of radiomics and machine learning in breast ultrasound: a multicenter study for differential diagnosis of benign and malignant lesions

Radiomics Based on Multimodal MRI for the Differential Diagnosis of Benign and Malignant Breast Lesions

Accuracy of radiomics in the diagnosis and preoperative high-risk assessment of endometrial cancer: a systematic review and meta-analysis

Added Value of Radiomics on Mammography for Breast Cancer Diagnosis: A Feasibility Study.

The Diagnostic Performance of Machine Learning-Based Radiomics of DCE-MRI in Predicting Axillary Lymph Node Metastasis in Breast Cancer: A Meta-Analysis

Radiomics in distinguishing between lung adenocarcinoma and lung squamous cell carcinoma: a systematic review and meta-analysis

Breast Ultrasound-Based Deep Learning Radiomics Model for Differentiating Malignancy in Low Malignant Risk Lesions

Ultrasound Radiomics‐Based Logistic Regression Model to Differentiate Between Benign and Malignant Breast Nodules

Machine Learning Based on Automated Breast Volume Scanner (ABVS) Radiomics for Differential Diagnosis of Benign and Malignant BI‐RADS 4 Lesions